Bicycle Health Honored as one of Time Magazine’s 100 Most Influential Companies of 2022

March 31, 2022

BOSTON, MA—Bicycle Health, the leading virtual care provider of evidence-based treatment for opioid use disorder (OUD), was honored by Time Magazine as one of the TIME100 Most Influential Companies of 2022.

More than 78,000 Americans died of opioid overdoses last year and more than 40% of U.S. counties lack a single OUD practitioner. Bicycle Health, which delivers OUD treatment via telemedicine, attempts to fill that void virtually by offering medication management, support groups, at-home drug testing and more for an affordable price. To date, Bicycle Health has helped more than 14,000 patients across the U.S. in their battles against OUD.

Questa Capital is proud to partner with Bicycle Health in its mission to provide high quality and affordable opioid use disorder treatments for those in need.

About Bicycle Health

Bicycle Health offers confidential evidence based virtual care for opioid use disorder, from the comfort of your home.  We provide access to a highly trained team of medical experts, a customized treatment plan, same day prescription refills for medication management and access to peer support groups and therapy. Our mission is to provide high quality, affordable, convenient and confidential opioid use disorder treatment for those in need, with a vision to help anyone with a chronic disease live a happy, healthy and fulfilling life. More information is available at

About Questa Capital

Questa Capital is a venture growth equity firm focusing on investments in expansion-stage healthcare companies. Questa seeks out disruptive, technology-enabled business models that help improve patient lives, streamline market inefficiencies, and provide better quality care. The firm partners with superior management teams to help build innovative market leaders in the healthcare technology, services and medical devices sectors. Questa is led by industry veterans in healthcare investment and operations who have invested in and advised more than 50 growth-stage companies. More information is available at